Fig 1: Diffusion‐based MR‐histology. A color‐coded synthesized MR‐histology (T2, ADC, FA) highlights histological features, such as the white matter (yellow arrows), DG (brown arrows) and CA1 cell layers (orange arrows), as well as tissue damage (white *). Myelinaed fibers (yellow arrows) of the subiculum are also evident. The tissue characteristics are also evident on fluorescent histology (DAPI, GFAP, MBP, FOX3). [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Fig 2: Comparison of MR histology with immunohistochemistry. A multislice overview of MR histology (T2, ADC, FA) and its correspondence to post‐mortem fluorescent histology (DAPI, GFAP, MBP, FOX3). It is evident that MR histology provides a similar mesoscale assessment of the hippocampus to histology, but does not suffer from potential cutting artifacts and hence a more complete view of the sample in 3D is available. Nevertheless, histology is required to provide a more detailed molecular characterization of anatomical features. [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Fig 3: Functional deletion of Lpar1 is cre‐dependent. A, PCR products of DNA isolated from Lpar1flox/flox (F/F) and Lpar1flox/flox‐nestin‐cre transgenic (F/F NC Tg) DRG shows genomic deletion of Lpar1 exon 3 DNA from the tail of a Wt mouse is shown for comparison. B, qPCR products of cDNA prepared from Lpar1flox/flox (F/F) and Lpar1flox/flox‐nestin‐cre transgenic (F/F NC Tg) DRG shows that Lpar1 transcripts are lost in neural tissues. C, PCR of genomic DNA isolated from the tail of a Wt mouse (Wt) and the sciatic nerve of Lpar1flox/flox (F/F) and Lpar1flox/flox‐P0‐cre (F/F P0) mice. D, PCR amplification of genomic DNA isolated from the sciatic nerve (SN) and cortex (Ctx) of Lpar1flox/flox and Lpar1flox/flox‐synapsin‐cre mice. The PCR primers used for amplification of Wt (316 bp), Lpar1 floxed alleles (354 bp), and Lpar1 deleted products (242 bp) are identical to those used in Figure 2B. The 100, 200, 300, and 400 bp bands of the 1kb plus DNA ladder are indicated for reference. E and F, Immunofluorescent labeling of peripheral myelinated axons identify Wt LPA1 immunolabeling in Lpar1flox/flox mice (E) and its absence (F) in Lpar1flox/flox‐nestin‐cre transgenic mice. LPA1 labeling is in green and MBP (myelin) in red for individual samples. Scale bar = 100 µM.
Fig 4: Morphology of the spinal cord by group confirmed by EC staining and IHC staining and IHC analysis. (A) Eriochrome cyanine staining of spinal cord cross-sections for myelin in all groups (sham, SCI, aSCI_Ctrl, aSCI_CS, cSCI_CS). Scale bar shown 400 μm. (B) Eriochrome cyanine staining of spinal cord longi section for myelin in all groups (sham, SCI, aSCI_Ctrl, aSCI_CS, cSCI_CS). Scale bar shown 400 μm. (C) The total cord area, cavity area, myelinated area, and gray matter area were quantified by image analysis. All data were processed using two-way analysis of variance with Tukey's multiple comparisons test. (D) MBP(Red), GFAP(Gray), and eYFP(Green), DAPI(Blue) IHC staining confocal images. The first image for each group is a 10× magnification of the box-marked area in the merge section. The scale bar shown 2 μm and 20 μm. (E) Quantification results of the intensity of eYFP+, MBP+ and GFAP+. Analysis was conducted using ordinary one-way ANOVA with Tukey's multiple comparisons test. The p-values are indicated as follows: ±SEM (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, and ∗∗∗∗p < 0.0001).
Fig 5: MAOB inhibition with KDS2010 reduces astrocytic GABA levels and enhances proBDNF and TrkB expression after SCI. a Differential interference contrast (DIC) images of the dorsal horn of the spinal cord (top and middle) and a magnified view of a whole-cell patch-clamped lamina II neuron (bottom). The yellow boxes indicate the magnified region of interest. b Representative traces of GABAA receptor-mediated tonic GABA current in each group (Sham+V, SCI + V, and SCI + KDS 2w). The dashed lines (gray) and double-headed arrows (purple and brown) indicate baseline shifts (IGABA and ITonic) with bath application of GABA (10 μM, green bar) and bicuculline (Bic, 50 μM, orange bar). c Tonic GABA current density (top, left), GABA-induced full activation current density (top, right), frequency (bottom, left) and amplitude (bottom, right) of spontaneous inhibitory postsynaptic currents (sIPSCs) in each group. d Confocal images of the injured areas stained with anti-proBDNF (green), anti-GABA (red), anti-NeuN (magenta), and anti-GFAP (white) antibodies at PI 10w in SCI + V and SCI + KDS 2w. e Mean intensity of GABA (left), NeuN-positive proBDNF (middle), GFAP-positive proBDNF (right). f Western blotting of BDNF and TrkB in Sham+V, SCI + V, and SCI + KDS 2w at PI 10w. g Quantification of BDNF (left) and TrkB (right) expression levels in Western blotting. β-actin was used as a control for protein amount. h Experimental timeline for quantitative real-time PCR with GABA (100 μM) or Bic (50 μM) treatment of primary cultured spinal cord astrocytes at 14 days in vitro (DIV). i Relative (comparative Ct) BDNF expression level of each drug treatment condition (GABA, GABA+Bic, and Bic). j Representative images of control and GABA-treated spinal cord astrocytes. k Western blotting of proBDNF in control and GABA-treated condition. l Quantification of proBDNF in Western blotting. β-actin was used as a control for protein amount. m Confocal images of the injured areas stained with anti-TrkB (green), DAPI (blue), and each Tau, MBP, or GFAP (red) antibodies at PI 10w. KDS2010 treatment was initiated at PI 2w and continued daily until PI 10w. Group labels indicate the treatment start point. n Mean intensity of TrkB in the Tau-positive neurons (left), MBP-positive oligodendrocytes (middle), and GFAP-positive astrocytes (right) at PI 10w. All the data are expressed as the means ± S.E.M.s *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not significant
Supplier Page from Abcam for Anti-Myelin Basic Protein antibody